Related Experiment Video
Updated: Jul 23, 2026
07:51
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
Published on: May 21, 2018
[Drug interactions. Mechanisms and clinical relevance]
1Dr.-Margarete-Fischer-Bosch-Institut für Klinische Pharmakologie, Stuttgart. ulrich.klotz@ikp-stuttgart.de
Der Internist
|December 23, 2003
Summary
Drug interactions pose significant risks, leading to adverse effects and market withdrawals. Understanding drug metabolism and transport interactions is crucial for patient safety and effective polypharmacy management.
Area of Science:
- Pharmacology
- Drug Interactions
- Clinical Pharmacy
Context:
- Recent market withdrawals of terfenadine, mibefradil, and cisapride highlight serious drug-drug interaction risks.
- Polypharmacy is common, particularly in elderly patients, increasing the likelihood of drug interactions.
- Drug interactions can lead to adverse effects, therapeutic failures, hospitalizations, and increased healthcare costs.
Purpose:
- To emphasize the importance of considering pharmacokinetic and pharmacodynamic drug interactions.
- To highlight that drug metabolism and transport are key levels for clinically relevant interactions.
- To illustrate the variable interaction potential among drugs, using proton pump inhibitors as an example.
Summary:
- Drug interactions, particularly those affecting drug metabolism and transport, are a significant concern in clinical practice.
- Both induction and inhibition of these processes by various agents can lead to adverse events and treatment failures.
- The potential for drug interactions varies, as demonstrated by differences among proton pump inhibitors.
Impact:
- Enhanced awareness of drug interaction risks can prevent adverse drug events and hospital admissions.
- Informed polypharmacy management can improve therapeutic outcomes and reduce healthcare expenditures.
- Further research into drug interaction mechanisms and prediction is essential for patient safety.
Related Concept Videos
01:29Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
01:30Combined Effects of Drugs: Antagonism
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
01:14Agonism and Antagonism: Quantification
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...